Very recently, a role for CD133 and the Src kinase in the regulation of tumour initiating properties and the transition from an epithelial to a mesenchymal phenotype of head and neck carcinoma cells has been demonstrated [11]. This evidence concerns the gene PROM1 and neoplasm.